Marie Skłodowska-Curie Doctoral Network NANOREMEDI-programme in “Functional Nano-Scaffolds for Regenerative Medicine” stems from six Doctoral Courses/Schools at six beneficiary institutions, providing research and training in the field of nanomaterials for Regenerative Medicine. An active contribution of enterprises in training activities is a relevant feature of the programme.
Beneficiaries (Doctorate Courses/Schools): University of Milan (Pharmaceutical Sciences), ITALY – Coordinating University; Universitat Politècnica de Catalunya (Polymers and Biopolymers) SPAIN; The Hebrew University Jerusalem (School of Chemistry), ISRAEL; Université de Montpellier (Balard Chemical Sciences doctoral school), FRANCE; University of Pavia (Bioengineering, Bioinformatics & Health Technologies), ITALY; IC nanoGUNE (Materials Physics; delivered by University of the Basque Country - Associated Partner linked to NANOGUNE beneficiary), SPAIN.
Associated partners for secondments activities: Bayer Health Care Pharmaceuticals – ITALY; Edelweiss Connect GMBH – SWITZERLAND; Italfarmaco S.p.A. (CHEMI) – ITALY; Jacobacci & Partners – ITALY; Lynxter -FRANCE; Simune Atomistics SL – SPAIN; Ponti & Partners, SLP – SPAIN; AbMedica – ITALY; DeLama – ITALY; Officine Innovazione Srl (Deloitte) – ITALY; Genepep – FRANCE; BioBasic Europe rsl - ITALY
The scientific approach proposed by NanoReMedi Consortium is strongly multidisciplinary and will involve a number of different state-of-the-art technologies and methodologies. Expected results are:
13 ESR PhD positions are offered by the Consortium related to different and multidisciplinary projects strongly interconnected involving different state- of-the-art technologies and methodologies: Computational chemistry; Chemical synthesis/peptide synthesis; Peptide based Nanomaterials (Soft materials/Hydrogels/Electrospinning) preparation and spectroscopic characterization; Production of vein graph; 3D-tissue fabrication; Biofilm prevention; Electrostimulated release of antimicrobial peptides
Each ESR will attend the following training activities: i) advanced courses and soft and transferable skill courses provided by University's doctorate courses/schools; ii) multidisciplinary courses/Summer delivered by NanoReMedi Network at the general Network Meetings/; iii) Nine-months secondment at one of the Beneficiary jointly awarding the doctoral degree to improve research methods complementary to those at home institution; iv) Three-months secondment at one of the enterprise where ESRs are expected to acquire complementary skills.
One position is available at the Institute of Chemistry of the Hebrew University in research project No. 12 titled "Synthesis of peptide-based coating that resists bacterial attachment and encourages the specific adhesion of muscle cells and endothelial cells for the coating of tissue engineered vascular grafts (TEVGs)" under the supervision of Prof. Meital Reches.
Secondments: i) nine months at University of Pavia to coat VGs with synthesized peptides and perform biological characterization (cytocompatibility, proliferation), ii) three months of enterprise secondment at Biobasic Europe s.r.l. to obtain specific expertise on tests for safety and efficiency evaluation.Benefits
Each ESR will receive a 36-month grant to cover his/her participation costs, living, travel and installation allowance, family allowance, as follows:
Total grant (36 months)
This amount varies because of the application of a correction coefficient to the living allowance of the country in which the researcher will be recruited.
The cost of the PhD educational activities, as well as all expenses related to travels performed to attend schools, workshops, and network-organized events, will be planned and sustained by the network through the HORIZON EUROPE MSCA- DOCTORAL NETWORK grant (Institutional Costs).
The ESR will be provided with office space and all facilities for his/her research programme.Eligibility criteria
There are strict eligibility requirements for the ESR positions in MSCA-DN. Please ensure to be qualified before applying, as ineligible candidates cannot be considered.
The Recruitment board will pay special attention to respect gender balance.Selection process
The ESR will be selected on the basis of the following criteria (in random order):
Applications must be submitted on www. nanoremedi.eu/APPLICATION by October 28th, 2022 at 17:00 central European time (https:// www. timeanddate.com/time/zones/cet) within November 27th 2022 at 17:00 central European time.
Applicants are required to submit the following documents by uploading them as a PDF file along with (or as one PDF attachment to) the application form. Instructions on submission are provided on www. nanoremedi.eu/APPLICATION. For more information, you may also contact firstname.lastname@example.org
Hand written applications and applications sent by email, post or fax will not be accepted.Offer Requirements
Chemistry: Master Degree or equivalent
Required Education Level 2nd Level Master Degree or Skills/Qualifications 2nd Level Master Degree (120 ECTS + 180 ECTS in a bachelor degree) or a Single Cycle Degree (minimum 300 ECTS), or a comparable university degree (Second Cycle qualification)Specific Requirements
Master degree in chemistry or chemistry biologyContact Information